Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres.

A thorough understanding of the factors affecting drug release mechanisms from surface-erodible polymer devices is critical to the design of optimal delivery systems. Poly(sebacic anhydride) (PSA) microspheres were loaded with three model drug compounds (rhodamine B, p-nitroaniline and piroxicam) with a range of polarities (water solubilities). The drug release profiles from monodisperse particles of three different sizes were compared to release from polydisperse microspheres. Each of the model drugs exhibited different release mechanisms. Drug distribution within the polymer was investigated by laser scanning confocal microscopy and scanning electron microscopy. Rhodamine, the most hydrophilic compound investigated, was localized strongly toward the microsphere surface, while the much more hydrophobic compound, piroxicam, distributed more evenly. Furthermore, all three compounds were most uniformly distributed in the smallest microspheres, most likely due to the competing effects of drug diffusion out of the nascent polymer droplets and the precipitation of polymer upon solvent extraction, which effectively "traps" the drug in the polymer matrix. The differing drug distributions were manifested in the drug release profiles. Rhodamine was released very quickly independent of microsphere size. Thus, extended release profiles may not be obtainable if the drug strongly redistributes in the microspheres. The release of p-nitroaniline was more prolonged, but still showed little dependence on microsphere size. Hence, when water-soluble drugs are encapsulated with hydrophobic polymers, it may be difficult to tailor release profiles by controlling microsphere size. The piroxicam-loaded microspheres exhibit the most interesting release profiles, showing that release duration can be increased by decreasing microsphere size, resulting in a more uniform drug distribution.

[1]  M A Tracy,et al.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.

[2]  B. Narasimhan,et al.  Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[3]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[4]  R. Langer,et al.  Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. , 1997, Biomaterials.

[5]  J. Tamada,et al.  The development of polyanhydrides for drug delivery applications. , 1992, Journal of biomaterials science. Polymer edition.

[6]  K. P. Rao,et al.  Gelatin microsphere cocktails of different sizes for the controlled release of anticancer drugs , 1996 .

[7]  K. Griebenow,et al.  Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide‐co‐glycolide) microspheres using the solid‐in‐oil‐in‐water technique , 2001, The Journal of pharmacy and pharmacology.

[8]  C. A. Foster,et al.  Apparatus for producing uniform solid spheres of hydrogen , 1977 .

[9]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of Biomedical Materials Research.

[10]  Robert Langer,et al.  Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal , 1988 .

[11]  Robert Langer,et al.  Polyanhydride microspheres as drug carriers I. Hot-melt microencapsulation , 1987 .

[12]  K. Kim,et al.  Spherical hydrogen pellet generator for magnetic confinement fusion research , 1981 .

[13]  J. Akbuğa Effect of Microsphere Size and Formulation Factors on Drug Release from Controlled-Release Furosemide Microspheres , 1991 .

[14]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.

[15]  S. Schwendeman,et al.  Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[16]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. , 1986, Journal of biomedical materials research.

[17]  R. Langer,et al.  Morphology of polyanhydride microsphere delivery systems. , 1990, Scanning microscopy.

[18]  B. Narasimhan,et al.  Microphase separation in bioerodible copolymers for drug delivery. , 2001, Biomaterials.

[19]  R. Upadhye,et al.  Fabrication of hollow silica aerogel spheres by a droplet generation method and sol--gel processing , 1989 .

[20]  B. Gander,et al.  A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. , 1995, Vaccine.

[21]  B. C. Thanoo,et al.  Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Cory Berkland,et al.  Precise control of PLG microsphere size provides enhanced control of drug release rate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[23]  C. Berkland,et al.  PLG Microsphere Size Controls Drug Release Rate Through Several Competing Factors , 2003, Pharmaceutical Research.

[24]  A. Moes,et al.  In vitro evaluation of the hydrolytic degradation of dispersed and aggregated poly(dl-lactide-co-glycolide) microspheres , 1997 .

[25]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[26]  Donald L. Wise,et al.  Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines , 1988 .

[27]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[28]  Balaji Narasimhan,et al.  Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. , 2002, Biomaterials.

[29]  C. Hendricks,et al.  Interaction of a Stream of Dielectric Spheres in an Electric Field in a High Vacuum , 1983, IEEE Transactions on Industry Applications.

[30]  N A Peppas,et al.  New challenges in biomaterials. , 1994, Science.

[31]  J. E. Peters,et al.  Experimental and theoretical study of a monodisperse spray , 1988 .

[32]  K. Kim Fabrication of Glass Micro- and Nanospheres from Liquid Precursors Using Droplet Generation and Sol-Gel Processing , 1994 .

[33]  A. D'emanuele,et al.  Characterization of chemical structure and morphology of eroding polyanhydride copolymers by liquid-state and solid-state 1H n.m.r. , 1999 .

[34]  J. Feijen,et al.  Microspheres for protein delivery prepared from amphiphilic multiblock copolymers. 2. Modulation of release rate. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[35]  D W Pack,et al.  Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[36]  J. E. Peters,et al.  Ah experimental and theoretical study of a Monodisperse spray , 1987 .